Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu
Tytuł pozycji:

The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification.

Tytuł:
The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification.
Autorzy:
Lim K; Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
Kalim S; Division of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA. Electronic address: .
Źródło:
Advances in chronic kidney disease [Adv Chronic Kidney Dis] 2019 Nov; Vol. 26 (6), pp. 427-436.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Review
Język:
English
Imprint Name(s):
Original Publication: Philadelphia, PA : W.B. Saunders, c2004-2022.
MeSH Terms:
Protein Carbamylation*
Protein Processing, Post-Translational*
Cardiovascular Diseases/*metabolism
Glycation End Products, Advanced/*metabolism
Kidney Failure, Chronic/*metabolism
Vascular Calcification/*metabolism
Animals ; Arteries ; Humans ; Kidney Failure, Chronic/complications ; Receptor for Advanced Glycation End Products/metabolism ; Uremia/complications ; Uremia/metabolism ; Vascular Calcification/etiology
References:
Cell Mol Biol (Noisy-le-grand). 1998 Nov;44(7):1025-33. (PMID: 9846884)
Antioxid Redox Signal. 2011 Jun 15;14(12):2337-46. (PMID: 21235354)
Sci Transl Med. 2013 Mar 6;5(175):175ra29. (PMID: 23467560)
Vasc Health Risk Manag. 2009;5(1):185-97. (PMID: 19436645)
J Am Chem Soc. 1947 Jun;69(6):1382-4. (PMID: 20249723)
Connect Tissue Res. 1989;19(1):77-92. (PMID: 2791558)
Diabetes Care. 2009 Jul;32(7):1218-20. (PMID: 19366975)
Eur J Clin Invest. 2015 Sep;45(9):976-85. (PMID: 26153098)
Biochem Biophys Res Commun. 1999 Mar 24;256(3):549-56. (PMID: 10080935)
N Engl J Med. 2005 Jul 21;353(3):238-48. (PMID: 16034009)
Matrix Biol. 2007 Apr;26(3):190-6. (PMID: 17156988)
J Biol Chem. 1967 Apr 10;242(7):1579-91. (PMID: 6067157)
J Am Soc Nephrol. 2013 Apr;24(5):853-61. (PMID: 23431074)
J Int Med Res. 2009 May-Jun;37(3):847-54. (PMID: 19589269)
J Lab Clin Med. 1998 May;131(5):425-31. (PMID: 9605107)
Circ Res. 2013 Aug 16;113(5):495-504. (PMID: 23852538)
Science. 1981 Jul 10;213(4504):222-4. (PMID: 12192669)
Diabet Med. 2018 Apr 23;:null. (PMID: 29687658)
Clin J Am Soc Nephrol. 2013 Nov;8(11):1927-34. (PMID: 23970130)
Diabetes Care. 1999 Sep;22(9):1543-8. (PMID: 10480523)
BMC Cardiovasc Disord. 2013 Mar 05;13:13. (PMID: 23497312)
J Mol Med (Berl). 2005 Nov;83(11):876-86. (PMID: 16133426)
BMC Musculoskelet Disord. 2017 May 25;18(1):214. (PMID: 28545441)
Kidney Int. 2018 Jul;94(1):72-90. (PMID: 29716796)
N Engl J Med. 1993 Jun 10;328(23):1676-85. (PMID: 8487827)
Diabetes Metab Rev. 1991 Dec;7(4):239-51. (PMID: 1813279)
Circulation. 2012 May 8;125(18):2243-55. (PMID: 22492635)
Eur J Clin Invest. 1997 Feb;27(2):97-108. (PMID: 9061302)
Mol Med. 2018 Nov 23;24(1):59. (PMID: 30470170)
Clin Chem Lab Med. 2003 Sep;41(9):1159-65. (PMID: 14598865)
Oncotarget. 2017 Dec 1;8(68):112841-112854. (PMID: 29348870)
J Clin Invest. 1987 Jun;79(6):1635-41. (PMID: 3584463)
J Diabetes. 2017 Feb;9(2):141-148. (PMID: 27556881)
Clin Chem Lab Med. 2014 Jan 1;52(1):33-8. (PMID: 23454717)
Mt Sinai J Med. 2003 Sep;70(4):232-41. (PMID: 12968196)
Free Radic Biol Med. 2000 Jun 15;28(12):1708-16. (PMID: 10946212)
Nephrol Dial Transplant. 2019 Dec 1;34(12):2018-2030. (PMID: 30778553)
Atherosclerosis. 2008 Dec;201(2):274-80. (PMID: 18371970)
PLoS One. 2013 Dec 04;8(12):e82506. (PMID: 24324801)
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):147-53. (PMID: 17082489)
PLoS One. 2016 Dec 14;11(12):e0165576. (PMID: 27973558)
Antioxid Redox Signal. 2012 Oct 15;17(8):1043-52. (PMID: 22462773)
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13915-20. (PMID: 9391127)
J Am Soc Nephrol. 2004 Nov;15(11):2857-67. (PMID: 15504939)
Bioconjug Chem. 2004 Jan-Feb;15(1):27-34. (PMID: 14733580)
J Am Diet Assoc. 2004 Aug;104(8):1287-91. (PMID: 15281050)
J Am Soc Nephrol. 2009 Jul;20(7):1453-64. (PMID: 19478096)
Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11767-72. (PMID: 15289604)
J Biol Chem. 1992 Jul 25;267(21):14998-5004. (PMID: 1378843)
Mol Metab. 2013 Dec 07;3(2):94-108. (PMID: 24634815)
Thromb Haemost. 2017 May 3;117(5):899-910. (PMID: 28382370)
Am J Physiol Renal Physiol. 2016 Mar 15;310(6):F511-7. (PMID: 26764205)
Diabetes Res Clin Pract. 2007 May;76(2):236-44. (PMID: 17097186)
Eur J Heart Fail. 2007 Dec;9(12):1146-55. (PMID: 18023248)
Dermatoendocrinol. 2012 Jul 1;4(3):259-70. (PMID: 23467327)
Sci Rep. 2015 Nov 12;5:16577. (PMID: 26560812)
Am J Kidney Dis. 2014 Nov;64(5):793-803. (PMID: 25037561)
Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1191-6. (PMID: 26712018)
Nutrients. 2017 Apr 28;9(5):. (PMID: 28452927)
Dis Markers. 2015;2015:153978. (PMID: 25852219)
Diabetes. 2013 Jun;62(6):2116-21. (PMID: 23396398)
Vascul Pharmacol. 2012 Nov-Dec;57(5-6):160-7. (PMID: 22750165)
Clin Chem. 2017 May;63(5):980-989. (PMID: 28280052)
Nephrol Dial Transplant. 2015 Jan;30(1):84-91. (PMID: 25074436)
Nat Med. 2007 Oct;13(10):1176-84. (PMID: 17828273)
J Biol Chem. 2018 Apr 27;293(17):6374-6386. (PMID: 29496995)
J Atheroscler Thromb. 2016 Oct 1;23(10):1178-1187. (PMID: 26961217)
Eur Heart J. 2014 Nov 14;35(43):3021-32. (PMID: 24658767)
J Vasc Res. 2009;46(6):572-80. (PMID: 19571577)
PLoS One. 2015 Jun 17;10(6):e0128452. (PMID: 26083729)
J Am Soc Nephrol. 2010 Nov;21(11):1852-7. (PMID: 20947625)
Diabetes. 1987 Jul;36(7):808-12. (PMID: 3556280)
J Am Soc Nephrol. 2011 Sep;22(9):1631-41. (PMID: 21804091)
J Am Geriatr Soc. 2009 Oct;57(10):1874-80. (PMID: 19682127)
Sci Rep. 2018 Sep 13;8(1):13730. (PMID: 30213959)
Biochemistry. 1965 Nov;4(11):2363-7. (PMID: 5881593)
Diabetes. 1997 Sep;46 Suppl 2:S19-25. (PMID: 9285494)
Diabetes Care. 2011 Feb;34(2):442-7. (PMID: 21270199)
N Engl J Med. 2009 Jan 8;360(2):129-39. (PMID: 19092145)
Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1622-30. (PMID: 19696406)
J Am Coll Cardiol. 2016 Oct 11;68(15):1664-1676. (PMID: 27712780)
J Proteome Res. 2009 Feb;8(2):754-69. (PMID: 19093874)
J Biol Chem. 1964 May;239:1411-4. (PMID: 14193831)
Kidney Int Suppl. 2001 Feb;78:S102-7. (PMID: 11168993)
Redox Biol. 2014 Jan 09;2:411-29. (PMID: 24624331)
Nephrology (Carlton). 2008 Dec;13(6):480-6. (PMID: 18518940)
Ther Apher Dial. 2008 Feb;12(1):28-32. (PMID: 18257809)
Metabolism. 2005 Mar;54(3):345-50. (PMID: 15736112)
J Diabetes Complications. 2004 Sep-Oct;18(5):282-8. (PMID: 15337502)
Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1809-1816. (PMID: 27445162)
Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E323-30. (PMID: 18477705)
J Clin Endocrinol Metab. 2006 Nov;91(11):4628-34. (PMID: 16926247)
Cardiovasc Res. 2018 Mar 15;114(4):590-600. (PMID: 29514202)
Clin Chem. 1996 Mar;42(3):482-3. (PMID: 8598126)
Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2587-93. (PMID: 16224056)
Med Clin North Am. 2012 Jan;96(1):57-65. (PMID: 22391251)
Cell Mol Life Sci. 2002 Jul;59(7):1117-28. (PMID: 12222959)
Kidney Int. 2015 Jun;87(6):1201-8. (PMID: 25671766)
Cardiovasc Diabetol. 2002 Apr 08;1:1. (PMID: 12119059)
Int J Mol Sci. 2016 Sep 16;17(9):. (PMID: 27649164)
Nephrol Dial Transplant. 2008 Sep;23(9):3033; author reply 3033-4. (PMID: 18556745)
Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1836-46. (PMID: 17158646)
J Pak Med Assoc. 2006 Jul;56(7):323-6. (PMID: 16900714)
Grant Information:
K23 DK106479 United States DK NIDDK NIH HHS; K23 DK115683 United States DK NIDDK NIH HHS
Contributed Indexing:
Keywords: Advanced glycation end products; Carbamylation; Chronic kidney disease; Protein modifications; Vascular calcification
Substance Nomenclature:
0 (Glycation End Products, Advanced)
0 (Receptor for Advanced Glycation End Products)
Entry Date(s):
Date Created: 20191214 Date Completed: 20200804 Latest Revision: 20201101
Update Code:
20240105
PubMed Central ID:
PMC6993873
DOI:
10.1053/j.ackd.2019.10.001
PMID:
31831121
Czasopismo naukowe
Considerable technological advances have enabled the identification and linkage of nonenzymatic post-translationally modified proteins to the pathogenesis of cardiovascular disease (CVD) in patients with kidney failure. Through processes such as the nonenzymatic carbamylation reaction as well as the formation of advanced glycation end products, we now know that protein modifications are invariably associated with the development of CVD beyond a mere epiphenomenon and this has become an important focus of nephrology research in recent years. Although the specific mechanisms by which protein modifications occurring in kidney failure that may contribute to CVD are diverse and include pathways such as inflammation and fibrosis, vascular calcification has emerged as a distinct pathological sequelae of protein modifications. In this review, we consider the biological mechanisms and clinical relevance of protein carbamylation and advanced glycation end products in CVD development with a focus on vascular calcification.
(Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies